Small fatty molecules may predict future relapse risk in early MS: Study - Multiple Sclerosis News Today
A groundbreaking study published in the Multiple Sclerosis Journal reveals that specific small fatty molecules, or lipids, in the blood can predict the future risk of relapses in individuals with early-stage Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS). Researchers found that lower levels of certain fatty molecules, including linolenic and oleic acids, were associated with higher relapse rates over time, while elevated saturated triglycerides and increased activity in specific metabolic pathways also signaled heightened risk. This discovery offers a crucial step towards more personalized and proactive management of MS, potentially enabling earlier intervention for those most vulnerable to disease progression.

















